InstalabHeart Health Panel
Should you take a Heart Health Panel test?
This test is most useful if any of these apply to you.
10 Biomarkers Included
- hs-CRPHigh-sensitivity C-reactive protein measures low-grade inflammation throughout the body, a driver of heart attacks separate from cholesterol.Elevated inflammation predicts events even when cholesterol is well controlled.
- Total CholesterolThe sum of cholesterol across all particles, giving the baseline context for the more specific markers in the panel.Useful as a starting point but too broad to guide action on its own.
- TriglyceridesTracks the fat circulating in your blood and is an early signal of insulin resistance and metabolic strain.High triglycerides often precede measurable blood sugar problems and point to a metabolic cause.
- LDL CholesterolThe most studied marker of heart disease risk, tracking the cholesterol most likely to lodge in artery walls and build plaque.Elevated LDL cholesterol is the clearest and most treatable driver of long-term cardiovascular risk.
- HDL CholesterolReflects the clearance side of the system, how well your body removes cholesterol from artery walls.Low HDL alongside high triglycerides signals a metabolic pattern rather than a dietary one.
- VLDL CholesterolEstimates cholesterol carried by the liver's triglyceride-rich particles, linking your fat and cholesterol readings.A high value points toward triglyceride-driven, metabolic risk.
- ApoBApolipoprotein B counts the total number of artery-damaging particles in your blood, the single most direct measure of artery disease risk in this panel.A high result signals more dangerous particles than your LDL cholesterol reveals, and risk tracks this number when the two disagree.
- Lipoprotein(a)A largely genetic particle that raises heart attack and stroke risk on its own, independent of your diet or other cholesterol numbers.A high result reflects inherited risk that stays with you and calls for earlier, more aggressive prevention.
- HbA1cA three-month average of blood sugar that reveals whether glucose problems are reshaping your lipids toward riskier particles.A rising result flags insulin resistance, a common reason normal LDL cholesterol still hides real risk.
- ALTA liver enzyme that can hint at fatty liver, a condition tied to insulin resistance and heart risk, though it is not a reliable stand-alone test for it.An elevated value suggests metabolic strain in the liver that often travels with the high-triglyceride, high-particle pattern.
About Heart Health Panel
A single cholesterol number can look reassuring while your arteries tell a different story. Heart disease builds from several forces at once, and most of them never show up on a standard cholesterol check.
This panel reads your risk from four angles in one blood draw: how much cholesterol you carry, how many artery-damaging particles you carry, how much inflammation is present, and how your metabolism is holding up. Together they catch the risk that a basic test leaves half-finished.
What This Panel Reveals
The first story is about cholesterol balance. Total cholesterol, LDL cholesterol, HDL cholesterol, and the liver's main fat-carrying particle (measured as VLDL cholesterol) describe how much cholesterol is being shipped into your arteries versus cleared back out. This is the layer a routine test already covers, and it remains the foundation.
The second story is about particle count. Apolipoprotein B, usually shortened to ApoB, counts the actual number of artery-clogging particles in your blood, since each one carries exactly one ApoB molecule. Cholesterol can look normal while the particle count runs high, and when the two disagree, risk follows the particle count.
The third story is inherited and inflammatory. Lipoprotein(a), written Lp(a), is a mostly genetic particle that raises risk even when LDL cholesterol is low. High-sensitivity C-reactive protein (hs-CRP) measures low-grade inflammation throughout the body, a signal that tracks with heart attack risk and is largely independent of your cholesterol.
The fourth story is metabolic. Triglycerides, a three-month average of your blood sugar (HbA1c), and a liver enzyme called ALT reveal whether insulin resistance is quietly reshaping your lipids toward smaller, more numerous, more dangerous particles. A raised ALT can hint at fatty liver, though it is not a reliable stand-alone test for it. This is where 'normal' LDL cholesterol most often hides real risk.
How to Read Your Results Together
The value of this panel is in the combinations, not any single number. When markers disagree, the pattern tells you which pathway is driving your risk and what to do next.
| Pattern | What It Suggests |
|---|---|
| Normal LDL cholesterol but high ApoB | Many cholesterol-poor but numerous particles. Your risk is higher than your LDL number implies, and ApoB is the number to act on. |
| High triglycerides with low HDL cholesterol | An insulin-resistant, metabolic pattern rather than a dietary-cholesterol one. Check HbA1c and ALT for the underlying cause. |
| Well-controlled LDL cholesterol but high hs-CRP | Residual inflammatory risk. Cholesterol is handled, but inflammation is still driving events. |
| High Lp(a) with otherwise normal lipids | Inherited risk baked into your biology. It does not move much with diet and warrants earlier, more aggressive prevention. |
The most concerning result is not one high marker but several together. When artery-clogging particles, triglycerides, and inflammation all run high, risk compounds. In one large population study, people with LDL cholesterol, Lp(a), and hs-CRP all above the 75th percentile had a 77% higher risk of major cardiovascular events than those with all three at or below it, and a 58% higher risk even among people already on cholesterol-lowering medication.
What to Do with Your Results
If ApoB or LDL cholesterol is elevated, that is the clearest lever, and cholesterol-lowering therapy is the most evidence-backed response. If the pattern is metabolic, high triglycerides with low HDL and a rising HbA1c, the driver is usually insulin resistance, and diet, weight, and activity change the picture fastest. If hs-CRP stays high after your cholesterol is controlled, inflammation is worth a conversation with a clinician about further evaluation.
Lp(a) is a once-in-a-lifetime measurement for most people. It is genetically set and barely moves over years; repeat testing over a median of 4.42 years correlated at 0.96, meaning a single result is reliable. A high Lp(a) does not change, but it does raise the urgency of controlling everything else.
For the markers that do move, retest to confirm direction after any meaningful change. Triglycerides swing widely between draws, so two results need to differ by roughly 49% to be considered a real change, while LDL cholesterol needs about 16%. Retesting three to six months after a diet, weight, or medication change confirms whether the trend is real. A reasonable cadence for someone actively managing risk is annual tracking of the lipids, ApoB, hs-CRP, and HbA1c.
When Results Can Be Misleading
Two panel-wide confounders matter here. Triglycerides rise after meals, so a recent meal can distort them and the VLDL cholesterol calculated from them; a morning draw after fasting gives the cleanest read, though ApoB, HDL, and Lp(a) are unaffected either way and LDL cholesterol shifts only slightly. Separately, any recent infection, injury, or intense workout can temporarily spike hs-CRP, so a single high inflammation value during illness should be rechecked once you have recovered.